These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4226571)

  • 1. [Competitive inhibition of adenosine aminase as a possible cause of the coronary dilating effects of a pyrimidopyrimidine combination].
    Deuticke B; Gerlach E
    Naunyn Schmiedebergs Arch Pharmakol Exp Pathol; 1966; 255(1):107-19. PubMed ID: 4226571
    [No Abstract]   [Full Text] [Related]  

  • 2. The possible role of adenosine in the coronary dilator action of some pyrimidopyrimidines and pteridines.
    Nott MW
    Br J Pharmacol; 1970 Jun; 39(2):287-95. PubMed ID: 5425274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Symposium on problems in the clinical pharmacology of coronary dilators. Introduction].
    Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):121-7. PubMed ID: 4308585
    [No Abstract]   [Full Text] [Related]  

  • 4. [COMPETITIVE INHIBITION OF CATALYZED ADENOSINE DIFFUSION AS THE MECHANISM OF THE CORONARY DILATING EFFECT OF A PYRIMIDO-PYRIMIDINE DERIVATIVE].
    KUEBLER W; BRETSCHNEIDER HJ
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1964 Jul; 280():141-57. PubMed ID: 14253709
    [No Abstract]   [Full Text] [Related]  

  • 5. INFLUENCE OF A PYRIMIDOPYRIMIDINE DERIVATIVE ON DEAMINATION OF ADENOSINE BY BLOOD.
    BUNAG RD; DOUGLAS CR; IMAI S; BERNE RM
    Circ Res; 1964 Jul; 15():83-8. PubMed ID: 14196209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contents and role of adenosine in the heart and blood vessels].
    Czyzewicki T
    Pol Tyg Lek; 1971 Jun; 26(4):926-9. PubMed ID: 4936842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution of dipyridamole, a selective coronary dilating substance, between plasma, cellular and aqueous phase in man and dogs. A contribution on the dosage of the drug in man].
    Kübler W; Bretschneider HJ; Spieckermann PG
    Arzneimittelforschung; 1969 Feb; 19(2):185-90. PubMed ID: 5818756
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of action of dipyridamole: inhibition by dipyridamole of adenosine uptake in erythrocytes].
    Pfleger K; Niederau D; Volkmer I
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(2):118-30. PubMed ID: 4243212
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity.
    Camiener GW; Smith CG
    Biochem Pharmacol; 1965 Oct; 14(10):1405-16. PubMed ID: 4956026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adenosine-deaminase activity of myocardium homogenates of normal rats and rats pretreated with dipiridamole].
    Sopena M; Vázquez de Prada JR; Herreros B
    Rev Esp Fisiol; 1972 Sep; 28(3):189-92. PubMed ID: 4679510
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contents and role of adenosine in the heart and blood vessels].
    Czyzewicki T
    Pol Tyg Lek; 1971 Jun; 26(4):926-9. PubMed ID: 4948279
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the therapy of chronic coronary insufficiency].
    Steim H; Heilmeyer L
    Med Klin; 1966 Aug; 61(31):1223-8. PubMed ID: 5988938
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the formation of adenosine in the myocardium of different animal species in oxygen deficiency].
    Gerlach E; Deuticke B
    Klin Wochenschr; 1966 Nov; 44(22):1307-10. PubMed ID: 4966943
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of pyrimidopyrimidine and pteridine derivatives on phosphate and adenosine permeability in human erythrocytes].
    Gerlach E; Deuticke B; Koss FW
    Arzneimittelforschung; 1965 May; 15(5):558-63. PubMed ID: 5898300
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition, by aminophylline (theophylline-ethylenediamine), of the coronary dilating effect of adenosine, dipyridamole, hexabendin and ASTA C 4898].
    Spieckermann PG; Hellberg K; Kettler D; Reploh HD; Strauer B
    Pflugers Arch; 1969; 312(1):R15. PubMed ID: 5390218
    [No Abstract]   [Full Text] [Related]  

  • 17. Persantin.
    Med Lett Drugs Ther; 1966 Apr; 8(7):27-8. PubMed ID: 4956154
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coronary-angiographic demonstration of the dilating effect of dipyridamole on coronary arteries and its inhibition by caffeine (author's transl)].
    Diamantopoulos G; Matthes D; Goerttler U; Roth FJ; Juchelka W; Schmier J; Wenz W
    Arzneimittelforschung; 1975 Sep; 25(9):1396-1400. PubMed ID: 1242661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition of adenosine deaminase by urea, guanidine, biuret, and guanylurea.
    Ronca G
    Biochim Biophys Acta; 1967 Jan; 132(1):214-6. PubMed ID: 6030356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.